METEORIC-HF (Completed)
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction and Decreased Exercise Tolerance
- Medicine
- Omecamtiv Mecarbil
- Population
- Heart failure
- Phase
- III
- Starting year
- 2018
- More information
- Clinicaltrials.gov